Based on the currently available evidence, the overall risk related to omicron remains very high. Omicron has a significant growth advantage over delta, leading to rapid. Omicron appears to show preference for infecting and replicating in the upper respiratory tract, compared to delta and other strains which prefer the lower respiratory tract.
The variant was given the name omicron. While omicron was less severe compared to delta, there were still a significant number of deaths due to this variant worldwide. Considering the available evidence, the additional public.